Foresite Capital Management V, LLC Diversified Active

CIK: 0001792206 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 13, 2022

Total Value ($000): $244,877 (100.0% shares, 0.0% debt)

Holdings (17)

— Pardes Biosciences Inc 27.7%

Value ($000) $67,872 Shares 9,400,515 Est. Cost $16.37 Unrealized —

— Theseus Pharmaceuticals, Inc. 15.1%

Value ($000) $37,043 Shares 3,212,732 Est. Cost $12.68 Unrealized —

— Somalogic, Inc. 12.2%

Value ($000) $29,886 Shares 3,726,472 Est. Cost $12.39 Unrealized —

ACRS Aclaris Therapeutics, Inc. 8.9%

Value ($000) $21,692 Shares 1,258,243 Est. Cost $19.56 Unrealized -30.2%

HIMS Hims & Hers Health, Inc. 5.9%

Value ($000) $14,428 Shares 2,706,922 Est. Cost $10.11 Unrealized -51.1%

— Adicet Bio, Inc. 5.5%

Value ($000) $13,580 Shares 680,000 Est. Cost $17.49 Unrealized —

QSI Quantum-Si Incorporated 4.5%

Value ($000) $10,961 Shares 2,342,061 Est. Cost $10.48 Unrealized -53.5%

CGEM Cullinan Oncology, Inc. 4.2%

Value ($000) $10,392 Shares 992,507 Est. Cost $40.60 Unrealized -66.7%

— Kinnate Biopharma Inc. 4.0%

Value ($000) $9,853 Shares 875,001 Est. Cost $39.78 Unrealized —

IVVD Adagio Therapeutics, Inc. 2.7%

Value ($000) $6,529 Shares 1,431,826 Est. Cost $34.15 Unrealized -82.1%

CMPX Compass Therapeutics, Inc. 2.5%

Value ($000) $6,028 Shares 4,400,000 Est. Cost $3.29 Unrealized -37.2%

— Research Alliance Corp. II 2.0%

Value ($000) $4,880 Shares 500,000 Est. Cost $10.25 Unrealized —

— Gemini Therapeutics, Inc. 1.4%

Value ($000) $3,385 Shares 2,435,125 Est. Cost $13.55 Unrealized —

HLTHQ Cue Health Inc. 1.3%

Value ($000) $3,164 Shares 490,546 Est. Cost $11.81 Unrealized —

ENTA Enanta Pharmaceuticals, Inc. 1.2%

Value ($000) $3,007 Shares 42,250 Est. Cost $65.07 Unrealized 0.0%

— 23andMe Holding Co. 0.6%

Value ($000) $1,558 Shares 406,913 Est. Cost $11.69 Unrealized —

PHVS Pharvaris N.V. 0.3%

Value ($000) $619 Shares 34,142 Est. Cost $31.46 Unrealized -44.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Pardes Biosciences Inc	9,400,515	$67,872	27.7%	$16.37	—	COM	69945Q105
—	Theseus Pharmaceuticals, Inc.	3,212,732	$37,043	15.1%	$12.68	—	COM	88369M101
—	Somalogic, Inc.	3,726,472	$29,886	12.2%	$12.39	—	COM CL A	83444K105
ACRS	Aclaris Therapeutics, Inc.	1,258,243	$21,692	8.9%	$19.56	-30.2%	COM	00461U105
HIMS	Hims & Hers Health, Inc.	2,706,922	$14,428	5.9%	$10.11	-51.1%	COM CL A	433000106
—	Adicet Bio, Inc.	680,000	$13,580	5.5%	$17.49	—	COM	007002108
QSI	Quantum-Si Incorporated	2,342,061	$10,961	4.5%	$10.48	-53.5%	COM CL A	74765K105
CGEM	Cullinan Oncology, Inc.	992,507	$10,392	4.2%	$40.60	-66.7%	COM	230031106
—	Kinnate Biopharma Inc.	875,001	$9,853	4.0%	$39.78	—	COM	49705R105
IVVD	Adagio Therapeutics, Inc.	1,431,826	$6,529	2.7%	$34.15	-82.1%	COM	00534A102
CMPX	Compass Therapeutics, Inc.	4,400,000	$6,028	2.5%	$3.29	-37.2%	COM	20454B104
—	Research Alliance Corp. II	500,000	$4,880	2.0%	$10.25	—	COM CL A	760873109
—	Gemini Therapeutics, Inc.	2,435,125	$3,385	1.4%	$13.55	—	COM	36870G105
HLTHQ	Cue Health Inc.	490,546	$3,164	1.3%	$11.81	—	COM	229790100
ENTA	Enanta Pharmaceuticals, Inc.	42,250	$3,007	1.2%	$65.07	0.0%	COM	29251M106
—	23andMe Holding Co.	406,913	$1,558	0.6%	$11.69	—	COM CL A	90138Q108
PHVS	Pharvaris N.V.	34,142	$619	0.3%	$31.46	-44.1%	COM	N69605108